Marta Lomnytska
Affiliated Researcher at Institutionen för kvinnors och barns hälsa; Reproduktiv hälsa
- E-mail:
- marta.lomnytska@uu.se
- Visiting address:
- MTC-huset, Dag Hammarskjölds väg 14B, 1 tr
752 37 Uppsala - Postal address:
- Akademiska sjukhuset
751 85 UPPSALA
More information is available to staff who log in.
Short presentation
This text is not available in English, therefore the Swedish version is shown.
Jag är tumörkirurg för gynekologisk cancer. Min forsknings huvudintresse är äggstockscancer. Jag bedriver projekt som handlar om kirugiska strategier vid primär och recidiverad äggstockscancer samt prediktion av postoperativa komplikationer. Jag är PI för analys av hyperterm intraperitoneal cytostatika behandling vid äggsockscancer i OVHIPEC-2 fas III internationell randomiserad klinisk studie. Jag bedriver studien över trombocytproteinmarkörer för diagnostik och uppföjlning av äggstockscancer.
Publications
Recent publications
- Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer. (2022)
- The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer. (2021)
- 464 Markers on platelet microvesicles for diagnostics of ovarian cancer (2021)
- Peritoneal cancer index predicts severe complications after ovarian cancer surgery (2021)
- Super-resolution microscopy can identify specific protein distribution patterns in platelets incubated with cancer cells (2019)
All publications
Articles
- Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer. (2022)
- The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer. (2021)
- 464 Markers on platelet microvesicles for diagnostics of ovarian cancer (2021)
- Peritoneal cancer index predicts severe complications after ovarian cancer surgery (2021)
- Super-resolution microscopy can identify specific protein distribution patterns in platelets incubated with cancer cells (2019)
- Platelet protein biomarker panel for ovarian cancer diagnosis (2018)
- The protein kinase SIK downregulates the polarity protein Par3 (2018)
- Complications Related To Surgery For Ovarian Cancer With Intestinal Involvement (2015)
- Protein profiling of genomic instability in endometrial cancer (2012)
- Impact of genomic stability on protein expression in endometrioid endometrial cancer (2012)
- Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis (2011)
- SIK phosphorylates and degrades Par3 to mediate tight junction disassembly during epithelial-mesenchymal transition (2011)
- Diagnostic protein marker patterns in squamous cervicalcancer (2010)
- Differential tissue-specific protein markers of vaginal carcinoma (2009)
- Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients (2006)
- Proteomics Success Story. Towards Early Detection of Breast and Ovarian Cancer (2006)
- TGFbeta1/Smad3 counteracts BRCA1-dependent repair of DNA damage (2005)
- Phosphoproteome profiling of transforming growth factor (TGF)-beta signaling (2005)
- Proteomics-based identification of proteins interacting with Smad3 (2004)
- Transforming growth factor-beta1-regulated proteins in human endothelial cells identified by two-dimensional gel electrophoresis and mass spectrometry (2004)
- Influence of IFN-alpha2b, TGF-beta1 and some chemotherapeutic agents on the proliferation of endothelial cells (2003)